{"entity":{"type":"insider","cik":"0001579247","url":"/insider/0001579247","json_url":"/insider/0001579247.json","name":"Bolte Axel","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2013-06-27","last":"2022-04-20","span_basis":"filed_date"},"name_variants":[{"name":"Bolte Axel","source":"filing","n_filings":7,"first_seen":"2013-06-27","last_seen":"2022-04-20"}],"transactions":[{"id":6698517,"accession":"0001209191-22-024917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-024917","line_url":"/filing/0001209191-22-024917#line-1","is_derivative":false,"issuer_cik":"0001579247","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001579247","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67750.0,"shares_display":"67,750","price_per_share":3.69,"price_display":"3.69","price_state":"stated","total_value":249997.5,"total_display":"249,997.50","total_whole":"249,998","shares_owned_after":258575.0,"shares_owned_after_display":"258,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-19","filed_date":"2022-04-20","scope":"insider"},{"id":4094185,"accession":"0001209191-21-043205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-043205","line_url":"/filing/0001209191-21-043205#line-2","is_derivative":false,"issuer_cik":"0001579247","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001579247","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66788.0,"shares_display":"66,788","price_per_share":0.0001,"price_display":"0.00","price_state":"stated","total_value":6.6788,"total_display":"6.68","total_whole":"7","shares_owned_after":190825.0,"shares_owned_after_display":"190,825","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":5206319,"accession":"0001104659-17-003573","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-17-003573","line_url":"/filing/0001104659-17-003573#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":4.83,"price_display":"4.83","price_state":"stated","total_value":28980.0,"total_display":"28,980.00","total_whole":"28,980","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-30","filed_date":"2017-01-23","scope":"insider"},{"id":2948157,"accession":"0001104659-16-125937","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-125937","line_url":"/filing/0001104659-16-125937#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":56.97,"price_display":"56.97","price_state":"stated","total_value":199395.0,"total_display":"199,395.00","total_whole":"199,395","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-03","filed_date":"2016-06-07","scope":"insider"},{"id":8743434,"accession":"0001104659-15-025159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-025159","line_url":"/filing/0001104659-15-025159#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":48.27,"price_display":"48.27","price_state":"stated","total_value":24135.0,"total_display":"24,135.00","total_whole":"24,135","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-30","filed_date":"2015-04-01","scope":"insider"},{"id":5042322,"accession":"0001209191-13-047664","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-047664","line_url":"/filing/0001209191-13-047664#line-1","is_derivative":false,"issuer_cik":"0001410939","issuer_name":"Ophthotech Corp.","issuer_ticker":"OPHT","issuer_name_source":null,"issuer_url":"/issuer/0001410939","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":22.0,"price_display":"22.00","price_state":"stated","total_value":44000.0,"total_display":"44,000.00","total_whole":"44,000","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-25","filed_date":"2013-10-07","scope":"insider"},{"id":5526840,"accession":"0001104659-13-052053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-13-052053","line_url":"/filing/0001104659-13-052053#line-1","is_derivative":false,"issuer_cik":"0001070081","issuer_name":"PTC THERAPEUTICS, INC.","issuer_ticker":"PTCT","issuer_name_source":null,"issuer_url":"/issuer/0001070081","owner_cik":"0001579247","owner_name":"Bolte Axel","owner_display_name":"Bolte Axel","owner_url":"/insider/0001579247","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-25","filed_date":"2013-06-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Director, Officer (Chief Executive Officer)","n_filings":2,"first_seen":"2021-06-25","last_seen":"2022-04-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001410939","name":"Ophthotech Corp.","url":"/issuer/0001410939","role":"Director","n_filings":4,"first_seen":"2013-10-07","last_seen":"2017-01-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001070081","name":"PTC THERAPEUTICS, INC.","url":"/issuer/0001070081","role":"Director","n_filings":1,"first_seen":"2013-06-27","last_seen":"2013-06-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001579247","retrieved_at":"2026-08-22T13:34:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}